Theophylline.
Napier-Flood
F E
FE
Scientific Affairs Department, Allergan Australia, Sydney, NSW.
Creese
B R
BR
D001249:Asthma / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D006801:Humans; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000378:metabolism; D011448:Prostaglandin Antagonists / Q000378:metabolism; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1 / Q000187:drug effects / Q000378:metabolism; D012132:Respiratory Muscles / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013806:Theophylline / Q000494:pharmacology* / Q000627:therapeutic use
D010975:Platelet Aggregation Inhibitors; D011448:Prostaglandin Antagonists; D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D013806:Theophylline; D000242:Cyclic AMP; D002118:Calcium